We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.86B
AUM Growth
+$480M
Cap. Flow
+$182M
Cap. Flow %
4.72%
Top 10 Hldgs %
47.14%
Holding
436
New
3
Increased
192
Reduced
24
Closed
8

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$33.1M
2
MSFT icon
Microsoft
MSFT
+$18.8M
3
AAPL icon
Apple
AAPL
+$8.59M
4
AMZN icon
Amazon
AMZN
+$6.28M
5
META icon
Meta Platforms (Facebook)
META
+$4.57M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.48M
2
ANSS
Ansys
ANSS
+$2.38M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.67M
4
JNPR
Juniper Networks
JNPR
+$1.37M
5
WDC icon
Western Digital
WDC
+$471K

Sector Composition

Rank Sector Weight
1 Technology 39.49%
2 Consumer Discretionary 14.58%
3 Financials 11.61%
4 Communication Services 10.72%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WEAV icon
401
Weave Communications
WEAV
$537M
$140K ﹤0.01%
20,963
+5,992
+40% +$46.1K
PLMR icon
402
Palomar
PLMR
$3.62B
$140K ﹤0.01%
1,197
– –
CVCO icon
403
Cavco Industries
CVCO
$4.21B
$139K ﹤0.01%
239
– –
DAR icon
404
Darling Ingredients
DAR
$9.5B
$131K ﹤0.01%
4,235
-2,230
-34% -$74.5K
ONT
405
Onterris Inc
ONT
$795M
$129K ﹤0.01%
4,700
– –
BFAM icon
406
Bright Horizons
BFAM
$4.01B
$121K ﹤0.01%
1,119
+467
+72% +$54.1K
LEN.B icon
407
Lennar Class B
LEN.B
$20.1B
$119K ﹤0.01%
994
– –
ERII icon
408
Energy Recovery
ERII
$459M
$112K ﹤0.01%
7,274
– –
IRON icon
409
Disc Medicine
IRON
$2.93B
$110K ﹤0.01%
1,668
+585
+54% +$34.8K
ALRM icon
410
Alarm.com
ALRM
$2.75B
$105K ﹤0.01%
1,975
– –
CMI icon
411
Cummins
CMI
$89.5B
$101K ﹤0.01%
240
– –
ACLX
412
DELISTED
Arcellx
ACLX
$100K ﹤0.01%
1,219
– –
NEOG icon
413
Neogen
NEOG
$2.59B
$93.8K ﹤0.01%
16,435
– –
RNAM
414
DELISTED
Avidity Biosciences
RNAM
$93.8K ﹤0.01%
+2,153
New +$87K
SMMT icon
415
Summit Therapeutics
SMMT
$10.4B
$92.7K ﹤0.01%
4,487
– –
CRBP icon
416
Corbus Pharmaceuticals
CRBP
$165M
$90.4K ﹤0.01%
7,150
– –
AUTL
417
Autolus Therapeutics
AUTL
$484M
$87.2K ﹤0.01%
53,522
– –
HRMY icon
418
Harmony Biosciences
HRMY
$2.06B
$80.6K ﹤0.01%
2,924
– –
CELC icon
419
Celcuity
CELC
$4.28B
$79.2K ﹤0.01%
+1,604
New +$64.2K
MREO
420
Mereo BioPharma
MREO
$50.4M
$78.8K ﹤0.01%
38,235
– –
HCAT icon
421
Health Catalyst
HCAT
$163M
$74.2K ﹤0.01%
26,050
– –
JANX icon
422
Janux Therapeutics
JANX
$934M
$72.3K ﹤0.01%
2,960
– –
GTES icon
423
Gates Industrial Corporation Ltd.
GTES
$7.44B
$60.6K ﹤0.01%
2,441
+1,124
+85% +$27.9K
CNM icon
424
Core & Main
CNM
$8.56B
$53.8K ﹤0.01%
999
– –
SHIM icon
425
Shimmick
SHIM
$168M
$52.2K ﹤0.01%
20,000
– –
14 15 16
17
18

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return

Avanza Fonder's Q3 2025 Portfolio in Review

As of Q3 2025, Avanza Fonder held 436 positions worth $3.86B, up 14% from $3.38B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Avanza Fonder deployed $182M of net new capital in Q3 2025, opening 3 new positions and adding to 192 existing holdings. Its largest new stake was Avidity Biosciences: 2,153 shares worth $93.8K.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $2.48M trimmed.

  • Avanza Fonder's largest Q3 2025 buy was Avidity Biosciences: 2,153 shares worth $93.8K.
  • Avanza Fonder added most to NVIDIA in Q3 2025, an estimated $33.1M increase.
  • Avanza Fonder's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $2.48M.
  • Avanza Fonder fully exited Ansys in Q3 2025, selling an estimated $2.38M.
  • Avanza Fonder's ten largest holdings make up 47% of its $3.86B portfolio in Q3 2025.
  • Avanza Fonder opened 3 new positions and closed 8 in Q3 2025.
  • Avanza Fonder's portfolio value rose 14% quarter-over-quarter to $3.86B.

Based on Avanza Fonder's 13F filing for Q3 2025, filed 16 Oct 2025.